ARTICLE | Clinical News
NanoString Breast Cancer Intrinsic Subtyping Assay update
August 8, 2011 7:00 AM UTC
NanoString began a validation study to evaluate its NanoString Breast Cancer Intrinsic Subtyping Assay on 1,000 samples from post-menopausal women with hormone receptor-positive, early stage breast ca...